This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Financial Statements
Consolidated Statement of Earnings
Consolidated Statement of Cash Flows
Consolidated Balance Sheet
Consolidated Balance Sheet (Parenthetical)
Consolidated Statement of Shareholders' Investment
Consolidated Statement of Shareholders' Investment (Parenthetical)
Notes to Financial Statements
Summary of Significant Accounting Policies
Supplemental Financial Information
Conclusion of TAP Pharmaceutical Products Inc. Joint Venture and Sale of Abbott's Spine Business
Financial Instruments, Derivatives and Fair Value Measures
Post-Employment Benefits
Taxes on Earnings
Segment and Geographic Area Information
Litigation and Environmental Matters
Incentive Stock Program
Debt and Lines of Credit
Business Combinations, Technology Acquisitions and Related Transactions
Goodwill and Intangible Assets
Restructuring Plans
Subsequent Events
Quarterly Results (Unaudited)
Schedule II Valuation and Qualifying Accounts
Other
Document and Entity Information
All Reports
Rendering Log